<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01//EN" "http://www.w3.org/TR/html4/strict.dtd">
<html xmlns:n1="urn:hl7-org:v3" xmlns:in="urn:lantana-com:inline-variable-data" xmlns:sdtc="urn:hl7-org:sdtc"><head>
<meta charset="utf-8"><!-- Do NOT edit this HTML directly: it was generated via an XSLT transformation from a CDA Release 2 XML document. --><title>Progress note - 10/23/2024</title><style type="text/css">
body {
  color: #003366;
  background-color: #FFFFFF;
  font-family: Verdana, Tahoma, sans-serif;
  font-size: 14px;
}

a {
  color: #003366;
  background-color: #FFFFFF;
}

h1 {
  font-size: 20px;
  font-weight: bold;
}

h2 {
  font-size: 18px;
  font-weight: bold;
}

h3 {
  font-size: 14px;
  font-weight: bold;
}

h4 {
  font-size: 14px;
  font-weight: bold;
}


table {
  width: 100%;
}

th {
  background-color: #ffd700;
}

td {
  padding: 0.1cm 0.2cm;
  vertical-align: top;
  background-color: #ffffcc;
}

.h1center {
  font-size: 20px;
  font-weight: bold;
  text-align: center;
  width: 80%;
}

.header_table{
  border: 1pt inset #00008b;
}

.td_label{
  font-weight: bold;
  color: white;
}

.content_span{
 font-family: Verdana, Tahoma, sans-serif;
 display: inline;
 white-space: pre-line;
}

.td_header_role_name{
  width: 20%;
  background-color: #3399ff;
}

.td_header_role_value{
  width: 80%;
  background-color: #ccccff;
}

.Bold{
  font-weight: bold;
}

.Italics{
  font-style: italic;
}

.Underline{
  text-decoration:underline;
}

.internal_format
{
	list-style: none;
	list-style-position:outside;
	margin:0;
	padding:0;
	border:0;
	border-collapse: collapse;
}
          </style></head><body><h1 class="h1center">Progress note - 10/23/2024</h1><table class="header_table"><tr><td class="td_header_role_name"><span class="td_label">Patient</span></td><td class="td_header_role_value">CHRISTINA L ROBINSON</td></tr><tr><td class="td_header_role_name"><span class="td_label">Date of birth</span></td><td class="td_header_role_value">October 7, 1976 </td></tr><tr><td class="td_header_role_name"><span class="td_label">Current Gender</span></td><td class="td_header_role_value">Female</td></tr><tr><td class="td_header_role_name"><span class="td_label">Race(s)</span></td><td class="td_header_role_value"><ul style="list-style: none;list-style-position:outside;margin:0;padding:0; "><li>White</li></ul></td></tr><tr><td class="td_header_role_name"><span class="td_label">Ethnicity</span></td><td class="td_header_role_value"><ul style="list-style: none;list-style-position:outside;margin:0;padding:0; "><li>Declined to Specify</li></ul></td></tr><tr><td class="td_header_role_name"><span class="td_label">Language(s)</span></td><td class="td_header_role_value"><ul style="list-style: none;list-style-position:outside;margin:0;padding:0; "><li>English (Preferred)</li></ul></td></tr><tr><td class="td_header_role_name"><span class="td_label">Contact info</span></td><td class="td_header_role_value"> Postal Address:<br/>272 W PIONEER BLVD<br/>MESQUITE, NV 89027-4944, US<br/><br/>Primary Home Phone:  702-515-9955<br/></td></tr><tr><td class="td_header_role_name"><span class="td_label">Patient IDs</span></td><td class="td_header_role_value">24781 2.16.840.1.113883.4.391.327376<br/>24781 2.16.840.1.113883.4.391.327376.1<br/>00001230489 2.16.840.1.113883.4.572<br/></td></tr></table><table class="header_table"><tbody><tr><td class="td_header_role_name"><span class="td_label">Document Id</span></td><td class="td_header_role_value">cfafcc44-679f-4daa-b261-04d6c4bd69ec 2.16.840.1.113883.4.391</td></tr><tr><td class="td_header_role_name"><span class="td_label">Document Created:</span></td><td class="td_header_role_value">February 28, 2025, 15:30:28, MST </td></tr></tbody></table><table class="header_table"><tbody><tr><td class="td_header_role_name"><span class="td_label">Performer </span></td><td class="td_header_role_value"><table class="header_table internal_format"><tbody><tr><td class="td_header_role_value internal_format">Kenneth Baird</td></tr><tr><td class="td_header_role_value internal_format">9980 S 300 W<br/>SANDY, UT 84070-3627, US<br/><br/>Tel:  888-434-8880<br/></td></tr></tbody></table></td></tr></tbody></table><table class="header_table"><tbody><tr><td class="td_header_role_name"><span class="td_label">Author</span></td><td class="td_header_role_value">eClinicalWorks</td></tr><tr><td class="td_header_role_name"><span class="td_label">Contact info</span></td><td class="td_header_role_value"><br/><br/><br/></td></tr></tbody></table><table class="header_table"><tbody><tr><td class="td_header_role_name"><span class="td_label">Encounter Id</span></td><td class="td_header_role_value">256145 2.16.840.1.113883.4.391.327376</td></tr><tr><td class="td_header_role_name"><span class="td_label">Encounter Type</span></td><td class="td_header_role_value">ambulatory</td></tr><tr><td class="td_header_role_name"><span class="td_label">Encounter Date</span></td><td class="td_header_role_value"> From October 23, 2024, 16:00:00   to October 23, 2024, 16:15:00  </td></tr><tr><td class="td_header_role_name"><span class="td_label">Encounter Location</span></td><td class="td_header_role_value">id:  2.16.840.1.113883.4.391.327376</td></tr><tr><td class="td_header_role_name"><span class="td_label">Responsible party</span></td><td class="td_header_role_value">Kenneth Baird</td></tr><tr><td class="td_header_role_name"><span class="td_label">Contact info</span></td><td class="td_header_role_value">9980 S 300 W<br/>SANDY, UT 84070-3627, US<br/><br/>Tel:  888-434-8880<br/></td></tr></tbody></table><table class="header_table"><tbody><tr><td class="td_header_role_name"><span class="td_label">Guarantor</span></td><td class="td_header_role_value">CHRISTINA ROBINSON<br/></td></tr><tr><td class="td_header_role_name"><span class="td_label">Contact info</span></td><td class="td_header_role_value"><br/><br/>Tel:  702-515-9955<br/></td></tr></tbody></table><table class="header_table"><tbody><tr><td class="td_header_role_name"><span class="td_label">Legal authenticator</span></td><td class="td_header_role_value">Kenneth Baird signed at October 23, 2024 </td></tr><tr><td class="td_header_role_name"><span class="td_label">Contact info</span></td><td class="td_header_role_value">9980 S 300 W<br/>SANDY, UT 84070-3627, US<br/><br/>Tel:  888-434-8880<br/></td></tr></tbody></table><table class="header_table"><tbody><tr><td class="td_header_role_name"><span class="td_label">Document maintained by</span></td><td class="td_header_role_value">Solutions HH</td></tr><tr><td class="td_header_role_name"><span class="td_label">Contact info</span></td><td class="td_header_role_value"><br/>Las Vegas, NV, US<br/><br/>Tel:  725-205-4350<br/></td></tr></tbody></table><h2><a name="toc">Table of Contents</a></h2><ul><li><a href="#id1">ALLERGIES</a></li><li><a href="#id2">REASON FOR VISIT</a></li><li><a href="#id3">MEDICATIONS</a></li><li><a href="#id4">Encounters</a></li><li><a href="#id5">ASSESSMENTS</a></li><li><a href="#id6">PLAN OF TREATMENT</a></li><li><a href="#id7">Procedure Notes</a></li><li><a href="#id8">Progress Notes</a></li><li><a href="#id9">History and Physical Notes</a></li></ul><hr align="left" color="teal" size="2"/><h3><a name="id1" href="#toc">ALLERGIES</a></h3><div><table width="100%" border="1"><thead><tr><th>Allergen (clinical drug ingredient)</th><th>Drug/Non Drug Allergy documented on EMR</th><th>Reaction</th><th>Allergy Type</th><th>Onset Date</th><th>Status</th></tr></thead><tbody><tr><td ID="allergy1">azithromycin</td><td>Azithromycin</td><td ID="reaction1">Unknown</td><td>Drug Allergy</td><td/><td>Active</td></tr></tbody></table></div><h3><a name="id2" href="#toc">REASON FOR VISIT</a></h3><div>Wound evaluation, L inner thigh,, l labia</div><h3><a name="id3" href="#toc">MEDICATIONS</a></h3><div><table width="100%" border="1"><thead><tr><th>Medication</th><th>SIG (Take, Route, Frequency, Duration)</th><th>Notes</th><th>Start Date</th><th>End Date</th><th>Status</th></tr></thead><tbody><tr><td ID="medication1">hydroCHLOROthiazide 25 MG</td><td ID="instruction1"> Oral for 30 Days</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication2">Latuda 80 MG</td><td ID="instruction2"> Oral for 14 Days</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication3">Furosemide 20 MG</td><td ID="instruction3"> Oral for 30 Days</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication4">Tresiba FlexTouch 100 UNIT/ML</td><td ID="instruction4"> Subcutaneous for 30 Days</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication5">NovoLOG FlexPen 100 UNIT/ML</td><td ID="instruction5"> Subcutaneous for 15 Days</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication6">buPROPion HCl ER (XL) 300 MG</td><td ID="instruction6"> Oral for 30 Days</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication7">BD AutoShield Duo 30G X 5 MM</td><td ID="instruction7"> for 30 Days</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication8">Haloperidol 5 MG</td><td ID="instruction8"> Oral for 30 Days</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication9">Potassium Chloride ER 10 MEQ</td><td ID="instruction9"> Oral for 30 Days</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication10">Jardiance 25 MG</td><td ID="instruction10"> Oral for 14 Days</td><td/><td/><td/><td>Active</td></tr></tbody></table></div><h3><a name="id4" href="#toc">Encounters</a></h3><div><table width="100%" border="1"><thead><tr><th>Encounter</th><th>Location</th><th>Date</th><th>Provider</th><th>Diagnosis</th></tr></thead><tbody><tr><td>HIGHLAND MANOR OF MESQUITE</td><td>272 W PIONEER BLVD MESQUITE, NV 89027-4944</td><td>10/23/2024</td><td>Kenneth Baird</td><td>Abrasion, left thigh, subsequent encounter S70.312D and Dermatitis associated with moisture L30.8</td></tr></tbody></table></div><h3><a name="id5" href="#toc">ASSESSMENTS</a></h3><div><table width="100%" border="1"><thead><tr><th>Encounter Date</th><th>Diagnosis</th><th>Assessment Notes</th><th>Treatment Notes</th><th>Treatment Clinical Notes</th><th>Section Notes</th></tr></thead><tbody><tr><td ID="ref1">10/23/2024</td><td>Abrasion, left thigh, subsequent encounter (ICD-10 - S70.312D)</td><td/><td/><td/><td/></tr><tr><td ID="ref2">10/23/2024</td><td>Dermatitis associated with moisture (ICD-10 - L30.8)</td><td/><td/><td/><td/></tr><tr><td ID="ref3">10/23/2024</td><td>Other</td><td/><td><p>Wound Orders: </p><p>Remove dressing, cleanse wound per standard wound care protocol and apply the following order:</p><p>Inner L Thigh:</p><p>wound bed:  zinc barrier cream, </p><p>cover:  bordered foam dressing  QD</p><p>If too moist, add silver alginate under dressing</p><p>Labia:</p><p>Anasept. zinc barrier cream  QD</p><p>OTA</p><p>Ensure creams are fully removed prior to reapplying</p><p>Pannus:</p><p>clean and dry BID</p><p>apply nystatin powder, </p><p>place wicking materials - changed QD</p><p>cover:  bordered foam dressing   TIW</p><p>R groin:</p><p>cover with silver alginate  QD</p><p>Care Coordination:</p><p>Send patient notes to following:</p><p>Highland Manor of Mesquite</p><p>T: 702-346-7666</p><p>F: 702-346-7276</p></td><td><p>Discussion:</p><p>10/23/24:  Labia resolved, L inner thigh wound improved.  d/c anasept wound gel, continue barrier cream.</p><p>10/16/24:  Labia wound reopened with slight breakdown,  Add zinc barrier cream for protection.  </p><p>Uncertain of Medihoney hydrogel remaining in place switch to creams and bordered dressing.</p><p>10/9/24:  abrasion on labia intact, treat protectively.  No cover secondary to location.</p><p>Abrasion inner L thigh, treat to heal and cover for protection.   Anticipate full healing,</p></td><td/></tr></tbody></table></div><h3><a name="id6" href="#toc">PLAN OF TREATMENT</a></h3><div><span class="content_span">Treatment Notes</span><table width="100%" border="1"><thead><tr><th>Assessment</th><th>Notes</th></tr></thead><tbody><tr><td ID="instructionpot1">Other</td><td><p>Wound Orders: </p><p>Remove dressing, cleanse wound per standard wound care protocol and apply the following order:</p><p>Inner L Thigh:</p><p>wound bed:  zinc barrier cream, </p><p>cover:  bordered foam dressing  QD</p><p>If too moist, add silver alginate under dressing</p><p>Labia:</p><p>Anasept. zinc barrier cream  QD</p><p>OTA</p><p>Ensure creams are fully removed prior to reapplying</p><p>Pannus:</p><p>clean and dry BID</p><p>apply nystatin powder, </p><p>place wicking materials - changed QD</p><p>cover:  bordered foam dressing   TIW</p><p>R groin:</p><p>cover with silver alginate  QD</p><p>Care Coordination:</p><p>Send patient notes to following:</p><p>Highland Manor of Mesquite</p><p>T: 702-346-7666</p><p>F: 702-346-7276</p></td></tr></tbody></table><span class="content_span">Next Appt</span><table width="100%" border="1"><thead><tr><th>Details</th></tr></thead><tbody><tr><td ID="nextAppt">Follow Up: 1 Week, Reason: for response to treatment, monitoring for infections and re-assessment of an everchanging wound</td></tr></tbody></table></div><h3><a name="id7" href="#toc">Procedure Notes</a></h3><div><ul><li><table width="100%" border="1"><colgroup><col width="20%"/><col width="20%"/><col width="40%"/><col width="20%"/></colgroup><thead><tr><th>Category</th><th>Sub-Category</th><th>Detail</th><th>Notes</th></tr></thead><tbody><tr><td rowspan="2">Wound Care Goals</td><td>Short term goals:</td><td colspan="2">minimize moisture/friction, Maintain skin barrier</td></tr><tr><td>Long term goals:</td><td colspan="2">complete wound healing</td></tr></tbody></table><br/></li></ul></div><h3><a name="id8" href="#toc">Progress Notes</a></h3><div><ul><li><table width="99%" border="0" cellspacing="0" cellpadding="0"><thead><tr><td><content>ROBINSON, CHRISTINA L <span class="bold">DOB:</span> 10/07/1976 (48 yo F) <span class="bold">Acc No.</span> 24781 <span class="bold">DOS:</span> 10/23/2024</content></td></tr></thead><tbody><tr><td><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td align="right" colspan="2"><span class="bold">Progress Notes</span></td></tr><tr><td align="left"><span class="bold">Patient: </span>ROBINSON, CHRISTINA L<br/><span class="bold">Account Number: </span>24781</td><td align="right"><span class="bold">Provider: </span>Kenneth Baird, PA</td></tr><tr><td align="left"/></tr><tr><td align="left"><span class="bold">DOB: </span>10/07/1976<span class="bold">   Age: </span>48 Y<span class="bold">   Sex: </span>Female</td><td align="right"><span class="bold">Date: </span>10/23/2024</td></tr><tr><td><span class="bold">Phone: </span>702-515-9955</td></tr><tr><td colspan="2"><span class="bold">Address: </span>272 W PIONEER BLVD, MESQUITE, NV-89027-4944</td></tr></tbody></table></li></ul><br/><content><span class="bold">Subjective:</span></content><br/><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Chief Complaints:</span></td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td>   Wound evaluationL inner thigh,L labia</td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">HPI: </span><br/>   <span class="Underline">*</span>: <br/>       Wound improved, now only a single wound on L inner thigh.<br/>       Facility reports she is non-compliant with fluid restriction and is constantly wet.<br/>       Christina is a 47 yo F who presents at Highland Manor or Mesquite for a wound evaluation. Patient was admitted to facility on 8/26/2019 for long term care.<br/>      Complicating Factors: Diabetes Mellitus, Hypertension, Insomnia, Heart failure, Tobacco Use, Muscle wasting/atrophy, COPD, Impaired mobility. Treatments Attempted: Nystatin/Triamcinolone Cream, Manuka honey, Medihoney, Skin prep, Nystatin Powder, Hydrogel/Anasept, Silver Alginate, Anasept, Zinc barrier cream. Patient is seen today at: Highland Manor, Skilled Nursing Facility where access to a wide range of health and personal care services can be provided. Care is focused on medical needs, nursing care, 24 hour supervision, assistance with meals, diet , medication management and assistance with daily living activities. Medications: Reviewed. See MAR.. Patient reports: No redness, swelling, warmth, and no other signs of acute active infection, No fever, chills, SOB, cough, chest pain, No changes affecting wound healing. Nutrition Status: Adequate. Pressure Reduction: Frequent repositioning. Venous Insufficiency: Has adequate circulation / oxygenation. </td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">ROS:</span> <br/>   <span class="Underline">ROS</span>: <br/>      Weight loss denies. chest pain denies. diarrhea denies. fever denies. chills denies. SOB denies. palpitations denies. cough denies. constipation denies. abdominal pain denies.   <br/>   </td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Medical History:</span> </td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Surgical History:</span> </td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Hospitalization/Major Diagnostic Procedure:</span> </td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Medications:</span> TakingbuPROPion HCl ER (XL) 300 MG Tablet Extended Release 24 Hour  Oral  BD AutoShield Duo 30G X 5 MM Miscellaneous    Haloperidol 5 MG Tablet  Oral  Potassium Chloride ER 10 MEQ Capsule Extended Release  Oral  Jardiance 25 MG Tablet  Oral  Furosemide 20 MG Tablet  Oral  Tresiba FlexTouch 100 UNIT/ML Solution Pen-injector  Subcutaneous  NovoLOG FlexPen 100 UNIT/ML Solution Pen-injector  Subcutaneous  hydroCHLOROthiazide 25 MG Tablet  Oral  Latuda 80 MG Tablet  Oral  Medication List reviewed and reconciled with the patientTaking buPROPion HCl ER (XL) 300 MG Tablet Extended Release 24 Hour  Oral  Taking BD AutoShield Duo 30G X 5 MM Miscellaneous    Taking Haloperidol 5 MG Tablet  Oral  Taking Potassium Chloride ER 10 MEQ Capsule Extended Release  Oral  Taking Jardiance 25 MG Tablet  Oral  Taking Furosemide 20 MG Tablet  Oral  Taking Tresiba FlexTouch 100 UNIT/ML Solution Pen-injector  Subcutaneous  Taking NovoLOG FlexPen 100 UNIT/ML Solution Pen-injector  Subcutaneous  Taking hydroCHLOROthiazide 25 MG Tablet  Oral  Taking Latuda 80 MG Tablet  Oral  Medication List reviewed and reconciled with the patient</td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Allergies:</span> Azithromycinno[Allergies Verified]</td></tr></tbody></table></li></ul><br/><content><span class="bold">Objective:</span></content><br/><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><content class="bold">Examination: <br/></content>   <span class="Underline">General Examination:</span><br/>      General appearance: Lying in bed, Well appearing, in no acute cardiopulmonary distress chaperone present in room<br/>        , Alert, Well Nourished, Comfortable, Pleasant, Cooperative, AAOx3, Answers questions appropriately, NAD. <br/>      Head: normocephalic, atraumatic. <br/>      Eyes: pupils equal, round, reactive to light and accommodation. <br/>      Ears: normal . <br/>      Neck / thyroid: Supple. <br/>      Skin: See Wound. <br/>      Heart: Capillary refill normal. <br/>      Lungs: Symmetrical chest rise, breathing unlabored. <br/>      Abdomen: WNL. <br/>      Extremities: No clubbing, no cyanosis.    <br/>   <span class="Underline">Wound #1:</span><br/>      Location: L inner thigh. <br/>      Age of Wound: 2 week(s),. <br/>      Wound Healing Status: Stable wound bed maintained . <br/>      Wound Type: Laceration with MASD. <br/>      Stage/Severity: limited to breakdown of skin . <br/>      Size: Current Measurements: , 0.5 cm L x 1.6 cm W x 0.2 cm D <br/>        Previous Measurements:, 2.7 cm L x 0.6 cm W x 0.2 cm D,. <br/>      Wound Bed: Pink, Red, Healthy, Dermal tissue 100%. <br/>      Wound Edges: Demarcated . <br/>      Periwound Tissues: Macerated, . <br/>      Drainage Amount: Scant . <br/>      Drainage Consistency: Serosanguineous . <br/>      Odor After Cleansing: None . <br/>      Wound Culture: No . <br/>      *Pain Level 2/10 .    <br/>   <span class="Underline">Wound #2:</span><br/>      Location: L labia. <br/>      Age of Wound: 2 week(s), . <br/>      Wound Healing Status: Resolved . <br/>      Wound Type: Abrasion/excoriation. <br/>      Size: Current Measurements: , intact<content><br/>        Previous Measurements:, _1.1__ cm L x _0.3__ cm W x _0__ cm D<br/>        </content>. <br/>      Wound Bed: Epithelialization 100%.    <br/></td></tr><tr><td/></tr></tbody></table></li></ul><br/><content><span class="bold">Assessment:</span></content><br/><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Assessment: </span></td></tr><tr><td/></tr><tr><td>1. Abrasion, left thigh, subsequent encounter - S70.312D (Primary) 2. Dermatitis associated with moisture - L30.8 </td></tr></tbody></table></li></ul><br/><content><span class="bold">Plan:</span></content><br/><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Treatment:</span></td></tr><tr><td><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">1. Others </span> <br/>Notes: Wound Orders: <br/><br/>Remove dressing, cleanse wound per standard wound care protocol and apply the following order:<br/><br/>Inner L Thigh:<br/>wound bed:  zinc barrier cream, <br/>cover:  bordered foam dressing  QD<br/>If too moist, add silver alginate under dressing<br/><br/>Labia:<br/>Anasept. zinc barrier cream  QD<br/>OTA<br/>Ensure creams are fully removed prior to reapplying<br/><br/>Pannus:<br/>clean and dry BID<br/>apply nystatin powder, <br/>place wicking materials - changed QD<br/>cover:  bordered foam dressing   TIW<br/><br/>R groin:<br/>cover with silver alginate  QD<br/><br/>Care Coordination:<br/>Send patient notes to following:<br/>Highland Manor of Mesquite<br/>T: 702-346-7666<br/>F: 702-346-7276<br/>  <br/>Clinical Notes: Discussion:<br/>10/23/24:  Labia resolved, L inner thigh wound improved.  d/c anasept wound gel, continue barrier cream.<br/>10/16/24:  Labia wound reopened with slight breakdown,  Add zinc barrier cream for protection.  <br/>Uncertain of Medihoney hydrogel remaining in place switch to creams and bordered dressing.<br/>10/9/24:  abrasion on labia intact, treat protectively.  No cover secondary to location.<br/>Abrasion inner L thigh, treat to heal and cover for protection.   Anticipate full healing,<br/><br/>  </td></tr><tr><td/></tr></tbody></table></li></ul></td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Procedures:</span> <br/>   <span class="Underline">Wound Care Goals</span>: <br/>      Short term goals:  minimize moisture/friction, Maintain skin barrier. Long term goals: complete wound healing.   <br/>      </td></tr><tr><td/></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Procedure Codes:</span> 99308 NURSING FAC CARE SUBSEQ</td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Preventive Medicine:</span> <br/>  MASD: MASD Monitor skin and check area routinely for changes in skin condition. Keep the resident clean and dry by changing their underpads or briefs after soiling, and use barrier creams or ointments after each bout of incontinence.  Dry the skin after bathing without rubbing or chaffing. Use proper antiperspirants, powders, clothing, and hair care to reduce heat and moisture buildup.. </td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Follow Up:</span> 1 Week (Reason: for response to treatment, monitoring for infections and re-assessment of an everchanging wound)</td></tr></tbody></table></li></ul><ul><li/></ul><br/><ul><li><table width="100%" border="0"><tbody><tr><td/></tr><tr><td valign="top"/></tr><tr><td/></tr><tr><td/></tr><tr><td valign="top">Electronically signed by Kenneth Baird , PAC  on 10/23/2024 at 10:41 PM MDT</td></tr><tr><td valign="top">Sign off status: Completed</td></tr><tr><td/></tr></tbody></table></li></ul><span class="content_span">true</span></td></tr></tbody><tbody><tr><td><br/><ul><li><table width="100%" border="0" cellpadding="0" cellspacing="0"><tbody><tr><td align="left"><span class="bold">Provider:</span> Kenneth Baird, PA</td><td align="right"><span class="bold">Date: </span>10/23/2024</td></tr></tbody></table></li></ul></td></tr></tbody></table></li></ul></div><h3><a name="id9" href="#toc">History and Physical Notes</a></h3><div><ul><li><p>HPI (History of Present Illness)</p><table width="100%" border="1"><colgroup><col width="20%"/><col width="20%"/><col width="40%"/><col width="20%"/></colgroup><thead><tr><th>Category</th><th>Sub-Category</th><th>Detail</th><th>Notes</th><th>Category Notes</th></tr></thead><tbody><tr><td rowspan="8">*</td><td>Complicating Factors:</td><td colspan="2">Diabetes Mellitus, Hypertension, Insomnia, Heart failure, Tobacco Use, Muscle wasting/atrophy, COPD, Impaired mobility</td><td rowspan="8"/></tr><tr><td>Treatments Attempted:</td><td colspan="2">Nystatin/Triamcinolone Cream, Manuka honey, Medihoney, Skin prep, Nystatin Powder, Hydrogel/Anasept, Silver Alginate, Anasept, Zinc barrier cream</td></tr><tr><td>Patient is seen today at:</td><td colspan="2">Highland Manor, Skilled Nursing Facility where access to a wide range of health and personal care services can be provided. Care is focused on medical needs, nursing care, 24 hour supervision, assistance with meals, diet , medication management and assistance with daily living activities</td></tr><tr><td>Medications:</td><td colspan="2">Reviewed. See MAR.</td></tr><tr><td>Patient reports:</td><td colspan="2">No redness, swelling, warmth, and no other signs of acute active infection, No fever, chills, SOB, cough, chest pain, No changes affecting wound healing</td></tr><tr><td>Pressure Reduction:</td><td colspan="2">Frequent repositioning</td></tr><tr><td>Nutrition Status:</td><td colspan="2">Adequate</td></tr><tr><td>Venous Insufficiency:</td><td colspan="2">Has adequate circulation / oxygenation</td></tr></tbody></table><br/><p>Examination</p><table width="100%" border="1"><colgroup><col width="20%"/><col width="20%"/><col width="40%"/><col width="20%"/></colgroup><thead><tr><th>Category</th><th>Sub-Category</th><th>Detail</th><th>Notes</th><th>Category Notes</th></tr></thead><tbody><tr><td rowspan="10">General Examination</td><td>General appearance:</td><td colspan="2">Lying in bed, Well appearing, in no acute cardiopulmonary distress chaperone present in room , Alert, Well Nourished, Comfortable, Pleasant, Cooperative, AAOx3, Answers questions appropriately, NAD</td><td rowspan="10"/></tr><tr><td>Head:</td><td colspan="2">normocephalic, atraumatic</td></tr><tr><td>Eyes:</td><td colspan="2">pupils equal, round, reactive to light and accommodation</td></tr><tr><td>Ears:</td><td colspan="2">normal</td></tr><tr><td>Neck / thyroid:</td><td colspan="2">Supple</td></tr><tr><td>Heart:</td><td colspan="2">Capillary refill normal</td></tr><tr><td>Lungs:</td><td colspan="2">Symmetrical chest rise, breathing unlabored</td></tr><tr><td>Abdomen:</td><td colspan="2">WNL</td></tr><tr><td>Skin:</td><td colspan="2">See Wound</td></tr><tr><td>Extremities:</td><td colspan="2">No clubbing, no cyanosis</td></tr><tr><td rowspan="14">Wound #1</td><td>Location:</td><td colspan="2">L inner thigh</td><td rowspan="14"/></tr><tr><td>Age of Wound:</td><td colspan="2">2 week(s),</td></tr><tr><td>Wound Healing Status:</td><td colspan="2">Stable wound bed maintained</td></tr><tr><td>Wound Type:</td><td colspan="2">Laceration with MASD</td></tr><tr><td>Stage/Severity:</td><td colspan="2">limited to breakdown of skin</td></tr><tr><td>Size:</td><td colspan="2">Current Measurements: , 0.5 cm L x 1.6 cm W x 0.2 cm D  Previous Measurements:, 2.7 cm L x 0.6 cm W x 0.2 cm D,</td></tr><tr><td>Wound Bed:</td><td colspan="2">Pink, Red, Healthy, Dermal tissue 100%</td></tr><tr><td>Wound Edges:</td><td colspan="2">Demarcated </td></tr><tr><td>Periwound Tissues:</td><td colspan="2">Macerated, </td></tr><tr><td>Drainage Amount:</td><td colspan="2">Scant </td></tr><tr><td>Drainage Consistency:</td><td colspan="2">Serosanguineous </td></tr><tr><td>Odor After Cleansing:</td><td colspan="2">None </td></tr><tr><td>Wound Culture:</td><td colspan="2">No</td></tr><tr><td>*Pain Level</td><td colspan="2">2/10</td></tr><tr><td rowspan="6">Wound #2</td><td>Location:</td><td colspan="2">L labia</td><td rowspan="6"/></tr><tr><td>Age of Wound:</td><td colspan="2">2 week(s),</td></tr><tr><td>Wound Healing Status:</td><td colspan="2">Resolved </td></tr><tr><td>Wound Type:</td><td colspan="2">Abrasion/excoriation</td></tr><tr><td>Size:</td><td colspan="2">Current Measurements: , intact Previous Measurements:, _1.1__ cm L x _0.3__ cm W x _0__ cm D </td></tr><tr><td>Wound Bed:</td><td colspan="2">Epithelialization 100%</td></tr></tbody></table><br/></li></ul></div><br/><br/></body></html>